Clinical Trial Update: Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating apatinib combined with SOX as neoadjuvant therapy for locally advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• SOX (SOX)

Snippet

Sponsor: Chang-Ming Huang, Prof. | Conditions: Apatinib Combined, SOX | Phase 2 | Status: UNKNOWN